The Rainwater Charitable Foundation’s Medical Research Program funds innovative research on tauopathies, supporting studies that advance understanding and treatment of tau-related neurodegenerative diseases.
Tau Pipeline Enabling Program V (T-PEP) supports researchers developing therapeutic candidates targeting tau or related mechanisms to advance potential disease-modifying treatments for tauopathies.
The Research Initiative Program by NTSAD funds research to advance understanding and treatment of Tay-Sachs, Canavan, GM1, and Sandhoff diseases through innovative science and collaboration.
Kissick Family Foundation Frontotemporal Dementia Grant Program (2026–2027) supports researchers studying sporadic FTD through basic and early translational science to advance understanding, diagnosis, and treatment.
Biomarker Accelerator Program supports researchers pursuing biomarker discoveries for progressive supranuclear palsy to accelerate diagnosis, treatment, research, or clinical care.
Research Grant Program supports investigators studying HSP and PLS, funding discovery and translational research to connect disease biology with therapeutic development, trial readiness, and patient benefit.